Pular para o conteúdo principal

TNF receptor superfamily member 11b

The TNFRSF11B gene provides instructions for making a protein that plays an important role in bone remodeling, a normal process in which old bone is broken down and replaced by new bone. The TNFRSF11B protein is involved in the regulation of specialized cells called osteoclasts, which break down bone tissue during bone remodeling.

Escolhas de vídeos para Genes
Biblioteca de vídeos

Normal function

The TNFRSF11B gene provides instructions for making a protein that plays an important role in bone remodeling, a normal process in which old bone is broken down and replaced by new bone. The TNFRSF11B protein is involved in the regulation of specialized cells called osteoclasts, which break down bone tissue during bone remodeling.

The TNFRSF11B protein belongs to a larger family of receptor proteins. Other proteins, called ligands, can fit into specific sites on receptor proteins like a key into a lock. Together, ligands and their receptors trigger signaling pathways that affect cell development and function. The TNFRSF11B protein works outside of the cell membrane.

The TNFRSF11B protein and a receptor protein called RANK can each attach to a ligand called RANKL. Because RANKL can only bind to one of these proteins at a time, the TNFRSF11B protein and RANK compete with one another. When RANKL is bound to RANK, a series of chemical signals cause osteoclasts to mature and turn on. This leads to the breakdown of bone. When RANKL is bound to the TNFRSF11B protein, these chemical signals are blocked. The TNFRSF11B protein is called a "decoy" receptor protein because no chemical signals are transmitted when RANKL is attached to this protein.

By influencing the amount of RANKL that is available to bind to RANK and activate osteoclasts, the TNFRSF11B protein plays a critical role in regulating the process of bone remodeling.

Conditions referring to this gene or chromosome

Other names

OCIF

OPG

osteoclastogenesis inhibitory factor

TR1

tumour necrosis factor receptor superfamily, member 11b

Related patient information and medicines

Imunossupressão

Patient information leaflet

Imunossupressão

Mycophenolate... Monoclonal antibodies - of which there are many ending in "mab", such as bevacizumab, rituximab and trastuzumab. Anti-TNF drugs such as etanercept Etanercept , infliximab, adalimumab, certolizumab and golimumab. (TNF stands for anti tumour necrosis factor, and some of the "mab" medicines above act against TNF, so there is some.

Medicamentos biológicos para artrite reumatoide

Patient information leaflet

Medicamentos biológicos para artrite reumatoide

They are made by living o... For example, some of these biological medicines block a chemical called tumour necrosis factor alpha (TNF-alpha) which plays an important role in causing inflammation in the joints. Medicines that block TNF incluem adalimumab, certolizumab pegol, etanercept, golimumab, and infliximab. The other biological medicines.

Hidradenite supurativa

Patient information leaflet

Hidradenite supurativa

Hidradenite supurativa is a long-term (chronic) skin condition that leads to painful and repeated lumps of pus (boils or abscesses). Hidradenitis suppurativa tends to run in families; about one-third of people with hidradenitis suppurative have a family member who is affected. The most promising of these treatments are monoclonal antibodies,.

Espondiloartrite axial

Patient information leaflet

Espondiloartrite axial

Biological medicines Biologics can be used to control the disease process. The main ones used for axial spondyloarthritis are called tumour necrosis factor (TNF) inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab or infliximab). Other medicines, such as secukinumab, bimekizumab or ixekizumab, may be used if TNF inhibitors have been.

Espondilite anquilosante

Patient information leaflet

Espondilite anquilosante

In ankylosing spondylitis, a chemical called cytokine tumour necrosis factor alpha (TNF-alpha) is involved in causing inflammation. Certain medicines in a group called TNF-alpha inhibitors... TNF-alpha inhibitors are also sometimes called anti-TNF-alpha drugs. In the UK the National Institute for Health and Care Excellence (NICE) recommends that.

Síndrome de Marfan

Patient information leaflet

Síndrome de Marfan

The following lists the most common problems and symptoms that may develop. Treatments are available for most of these problems. It can also cause head... What causes Marfan syndrome. Marfan syndrome is caused by a change (mutation) in the genéticas material on one of your chromosomes (chromosome number 15). The gene that is affected is responsible.

Leitura adicional e referências

Histórico do artigo

As informações nesta página são escritas e revisadas por clínicos qualificados.
  • 20 de nov de 2025 | Última versão
  • 1 Nov 2025 | Publicado originalmente

Participe da conversa

Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.

Aviso: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmácia online, tratamentos e serviços de saúde

Acesso simples a tratamentos confiáveis e serviços de saúde online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscreva-se no boletim informativo do Patient

Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.

Por favor, insira um endereço de e-mail válido

Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.